IW Capital backed Alesi Surgical Ltd's Ultravision2 robotic platform, which reduces CO₂ usage by up to 82% during laparoscopic surgery compared with high-flow insufflators.
Public source
Publisher name
Public post
🦾 Could greater efficiency make a difference in robotic surgery? Robotic platforms are a significant investment for operating theatres, making every efficiency around t…
Company
IW Capital
IW Capital is a venture capital firm focused on backing brilliant businesses.
- Industry
- Financial Services
- Location
- London, GB
- Company size
- 11–50 employees
About IW Capital
IW Capital is a venture capital firm focused on backing brilliant businesses. IW Capital originates, structures, leads, and manages investment opportunities for our expansive network of high net-worth and ultra-high net-worth investors, family offices, wealth managers and IFAs. With an executive team boasting over 100 years of collective experience in SME investment, IW Capital is renowned for its leading expertise in structuring and delivering funding to SMEs.
See moreLatest activity
Latest activity from IW Capital
4 signals
Capital & Finance
IW Capital led the latest investment round into Strolll, with £4.3m in funding from Innovate UK through a £3.6m innovation loan and a separate £700k Growth Catalyst Investor Partnerships (GCIP) award.
People
IW Capital-backed Navigator expanded its global team with exciting roles now open across its international offices.
Partnerships
IW Capital-backed Strolll expanded into Japan with Inter Reha Co.,Ltd as its official distribution partner in Fukuoka, Japan, marking a milestone in international growth.
Discover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
Colesco Capital
Colesco Capital published an article exploring how the Circular & Climate Credit Fund (C⁴IF) supports the commercialisation of circular and climate solutions.
Research & Knowledge
FCF Fox Corporate Finance GmbH
FCF Fox Corporate Finance GmbH identified current venture capital trends in the United States Healthcare and Life Sciences industry as of the end of June 2026, including total healthcare and life sciences funding reaching EUR 19,218m, biotech and pharmaceutical investment volume at 40%, and transaction volumes for NewLimit, Ollin Biosciences, and Beren Therapeutics.
Research & Knowledge
Healthy.Capital
Healthy.Capital portfolio company Guideways AI asked MedTech professionals to evaluate where AI could help with documentation, regulatory pathway, and submission over the next five years.
Research & Knowledge
Adaptation Ventures
Adaptation Ventures published a full piece and insights around fundraising, M&A, policy, and more in this month’s briefing.
Research & Knowledge
Pictet Group